SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-06-016234
Filing Date
2006-04-21
Accepted
2006-04-20 18:56:17
Documents
13

Document Format Files

Seq Description Document Type Size
1 v039957-f1.htm F-1 4799574
2 GRAPHIC xtl_bio-logo.jpg GRAPHIC 14399
3 v039957_ex1-1.htm EX-1.1 218280
4 v039957_ex1-2.htm EX-1.2 122590
5 v039957_ex1-3.htm EX-1.3 86603
6 v039957_ex1-4.htm EX-1.4 299860
7 v039957_ex4-5.htm EX-4.5 20791
8 v039957_ex5-1.htm EX-5.1 17211
9 v039957_ex10-20.htm EX-10.20 73654
10 v039957_ex23-2.htm EX-23.2 2819
11 v039957_ex23-3.htm EX-23.3 2391
12 v039957_ex23-4.htm EX-23.4 2400
13 v039957_ex23-5.htm EX-23.5 4040
  Complete submission text file 0001144204-06-016234.txt   5671482
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: F-1 | Act: 33 | File No.: 333-133445 | Film No.: 06771012
SIC: 2834 Pharmaceutical Preparations